MARATTO

article · Chemical Engineering Journal

Corrigendum to “Ultrasmall lactoferrin/lipid multicompartmental nanomedicine-based reprogramming of glycolysis in triple-negative breast cancer via HDAC6/LDH axis enhances cancer immunotherapy” [Chem. Eng. J. (CEJ) volume 514, 15 June 2025, 163015]

2025Open accessAlexandria University

In plain language

No abstract is available for this record, so no summary has been generated.

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.cej.2025.170985

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.